1. Home
  2. ONDS vs RIGL Comparison

ONDS vs RIGL Comparison

Compare ONDS & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONDS
  • RIGL
  • Stock Information
  • Founded
  • ONDS 2014
  • RIGL 1996
  • Country
  • ONDS United States
  • RIGL United States
  • Employees
  • ONDS N/A
  • RIGL N/A
  • Industry
  • ONDS Telecommunications Equipment
  • RIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONDS Telecommunications
  • RIGL Health Care
  • Exchange
  • ONDS Nasdaq
  • RIGL Nasdaq
  • Market Cap
  • ONDS 1.4B
  • RIGL 335.5M
  • IPO Year
  • ONDS N/A
  • RIGL 2000
  • Fundamental
  • Price
  • ONDS $5.86
  • RIGL $38.85
  • Analyst Decision
  • ONDS Strong Buy
  • RIGL Buy
  • Analyst Count
  • ONDS 3
  • RIGL 5
  • Target Price
  • ONDS $4.67
  • RIGL $38.20
  • AVG Volume (30 Days)
  • ONDS 49.3M
  • RIGL 995.6K
  • Earning Date
  • ONDS 08-12-2025
  • RIGL 08-05-2025
  • Dividend Yield
  • ONDS N/A
  • RIGL N/A
  • EPS Growth
  • ONDS N/A
  • RIGL N/A
  • EPS
  • ONDS N/A
  • RIGL 5.43
  • Revenue
  • ONDS $16,131,404.00
  • RIGL $267,921,000.00
  • Revenue This Year
  • ONDS $246.94
  • RIGL $59.93
  • Revenue Next Year
  • ONDS $161.09
  • RIGL N/A
  • P/E Ratio
  • ONDS N/A
  • RIGL $7.15
  • Revenue Growth
  • ONDS 75.16
  • RIGL 105.62
  • 52 Week Low
  • ONDS $0.57
  • RIGL $12.66
  • 52 Week High
  • ONDS $6.19
  • RIGL $43.72
  • Technical
  • Relative Strength Index (RSI)
  • ONDS 79.19
  • RIGL 68.57
  • Support Level
  • ONDS $3.20
  • RIGL $39.00
  • Resistance Level
  • ONDS $4.33
  • RIGL $42.08
  • Average True Range (ATR)
  • ONDS 0.54
  • RIGL 2.32
  • MACD
  • ONDS 0.17
  • RIGL -0.37
  • Stochastic Oscillator
  • ONDS 89.02
  • RIGL 53.26

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Share on Social Networks: